Genprex, Inc. (GNPX) stock price, news, quote and history

0&&s)if(o){var r,a=(r=e.newCount)>99;s.textContent=a?"99+":r+"",null===(t=s.parentElement)||void 0===t||t.classList.add(zt)}else s.style.display="block"},m=function(){d.refreshPanel().then(h).then(ee).catch((function(){}))};e.addEventListener("close-all-menus",(function(){Le(c)||u()})),c&&(m(),setInterval((function(){m()}),3e5),o?l&&l.addEventListener("mouseenter",(function(){p(),null==t||t.show()})):c.addEventListener("mouseenter",(function(){p(),null==t||t.show()})),c.addEventListener("mouseleave",(function(){u(),null==t||t.hide()}))),e.addElementListener(i,"click",(function(){Q("ybar","notification","",{elm:"btn",elmt:"block"===(null==s?void 0:s.style.display)?"newalert":"",subsec:"notification",itc:"1"})})),r&&Ee(e,r,"ybar","notification",{elm:"expand",subsec:"notifications",itc:"2"}),e.addElementListener(a,"focusin",(function(){i&&(i.checked=!0),null==a||a.classList.add("ybarMenuOpen")})),e.addElementListener(a,"focusout",u),e.addElementListener(n.tooltipContainer,"focusin",(function(){null==t||t.show()})),e.addElementListener(n.tooltipContainer,"focusout",(function(){null==t||t.hide()}));var f=e.getConfig().device,v=document.getElementById("ybar");v&&v.classList.contains("ybar-ytheme-crunch")&&(eo=0);var y=new RegExp("[?&]notifications=1(&|#|$)");"desktop"===f&&i&&y.test(window.location.search)&&(i.checked=!0)};ye("ybar-mod-notification",(function(e){var n={isUH3:"crunch"===e.getConfig().ytheme,notifContainer:document.getElementById("notification-container"),notifBadge:document.getElementById("notif-badge"),notifMenu:document.getElementById("ybarNotificationMenu"),notifMenuOpener:document.querySelector("#ybarNotificationMenu + label"),notifDropdown:document.getElementById("notifDropdownContainer"),tooltipContainer:document.querySelector(".".concat(Gt)),notifLabel:document.querySelector(".".concat(Wt))};to(e,n)}))}()}};

NasdaqCM - Delayed Quote • USD

Compare

1.4700 -0.0900 (-5.77%)

At close: 4:00 pm GMT-4

1.4500 -0.02 (-1.36%)

After hours: 5:18 pm GMT-4

Key events

Line

Candle

Baseline

Mountain

Bar

Advanced chart

Loading Chart for GNPX

9/21 12:03 PM

DELL

Date
Close
Open
High
Low
Volume

Previous close 1.5600
Open 1.5300
Bid --
Ask --
Day's range 1.4400 - 1.5399
52-week range 1.4400 - 29.6000
Volume 26,069
Avg. Volume 104,196
Market cap (intra-day) 3.085M
Beta (5Y monthly) -0.51
PE ratio (TTM) --
EPS (TTM) -18.8100
Earnings date 21 Aug 2024 - 26 Aug 2024
Forward dividend & yield --
Ex-dividend date --
1y target est 165.00

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes. Its oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's lead product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC. Its three lung cancer clinical programs have received a Fast Track Designation from the FDA for the treatment of that patient population, and SCLC program has received an FDA Orphan Drug Designation. The company's diabetes gene therapy comprises of a novel infusion process that uses an AAV vector to deliver Pdx1 and MafA genes directly to the pancreas. In models of Type 1 diabetes, its GPX-002 transforms alpha cells in the pancreas into functional beta-like cells, which produce insulin but distinct enough from beta cells to evade the body's immune system; and GPX-002 for Type 2 diabetes, where autoimmunity is not at play, is believed to rejuvenate and replenish exhausted beta cells. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.

www.genprex.com

Full-time employees

31 December

Fiscal year ends

Healthcare

Sector

Biotechnology

Industry

More about Genprex, Inc.

Recent news: GNPX

All SEC filings

Corporate changes and voting matters

Periodic financial reports

Proxy statements

Compare

Select to analyse similar companies using key performance metrics; select up to four stocks.

GNPXGenprex, Inc.

1.4700

-5.77%

Mkt cap 3.085M

Industry Biotechnology

RVPHReviva Pharmaceuticals Holdings, Inc.

0.9455

-6.39%

Mkt cap 28.192M

Industry Biotechnology

PASGPassage Bio, Inc.

0.8500

-8.60%

Mkt cap 52.395M

Industry Biotechnology

CRDFCardiff Oncology, Inc.

2.0650

-7.81%

Mkt cap 92.382M

Industry Biotechnology

CYDYCytoDyn Inc.

0.1310

-7.09%

Mkt cap 138.671M

Industry Biotechnology

ELEVElevation Oncology, Inc.

2.1300

-10.13%

Statistics: GNPX

Valuation measures

As of 02/08/2024

Market cap

3.29M
Enterprise value

-4.92M
Trailing P/E

--
Forward P/E

--
PEG ratio (5-yr expected)

--
Price/sales (ttm)

--
Price/book (mrq)

0.38
Enterprise value/revenue

--
Enterprise value/EBITDA

0.18

Financial highlights

Profitability and income statement

Profit margin

0.00%
Return on assets (ttm)

-96.86%
Return on equity (ttm)

-202.83%
Revenue (ttm)

--
Net income avi to common (ttm)

-27.63M
Diluted EPS (ttm)

-18.8100

Balance sheet and cash flow

Total cash (mrq)

8.22M
Total debt/equity (mrq)

--
Levered free cash flow (ttm)

-13.02M

Research analysis: GNPX

People also watch

DARE Daré Bioscience, Inc.

3.2628

-1.72%

CODX Co-Diagnostics, Inc.

1.0500

-3.67%

COCP Cocrystal Pharma, Inc.

1.7450

-4.64%

AIM AIM ImmunoTech Inc.

0.3226

-8.25%

AYTU Aytu BioPharma, Inc.

2.4300

-3.19%

OPGN OpGen, Inc.

2.5799

-8.84%

VTVT vTv Therapeutics Inc.

14.53

-1.22%

AGRX Agile Therapeutics, Inc.

1.4600

-0.68%

NNVC NanoViricides, Inc.

2.0200

-3.81%

CTXR Citius Pharmaceuticals, Inc.

0.9324

+2.86%

PIXY ShiftPixy, Inc.

1.2100

-12.32%

CAPR Capricor Therapeutics, Inc.

3.7700

-3.08%

CLSD Clearside Biomedical, Inc.

1.0900

-1.80%

HOTH Hoth Therapeutics, Inc.

0.6289

-10.62%

BSGM BioSig Technologies, Inc.

0.3320

-8.39%

VBIV VBI Vaccines Inc.

0.0629

-33.09%

Genprex, Inc. (GNPX) stock price, news, quote and history - Yahoo Finance (2024)

Full-time employees

Fiscal year ends

Sector

Industry

Recent news: GNPX

Performance overview: GNPX

YTD return

1-year return

3-year return

5-year return

Compare to: GNPX

Statistics: GNPX

Valuation measures

Financial highlights

Profitability and income statement

Balance sheet and cash flow

Research analysis: GNPX

People also watch

References